Mirae Asset Global Investments Co., Ltd. Novartis Ag Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 231,792 shares of NVS stock, worth $22.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

231,792

Previous 107,681 115.26%

Holding current value

$22.5 Million

Previous $11.5 Million 132.57%

% of portfolio

0.12%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$106.13 - $120.89 $13.2 Million - $15 Million	124,111 Added 115.26%	231,792 $26.7 Million
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $2.31 Million - $2.68 Million	24,954 Added 30.16%	107,681 $11.5 Million
Q1 2024 May 01, 2024	BUY	$95.27 - $108.47 $2.54 Million - $2.89 Million	26,632 Added 47.48%	82,727 $8 Million
Q4 2023 Jan 24, 2024	SELL	$92.27 - $101.54 $222,370 - $244,711	-2,410 Reduced 4.12%	56,095 $5.66 Million
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $2.8 Million - $3.18 Million	30,301 Added 107.44%	58,505 $5.9 Million
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $1.85 Million - $2.14 Million	-23,097 Reduced 45.02%	28,204 $2.59 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $795,617 - $974,328	-10,531 Reduced 17.03%	51,301 $4.65 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $5.16 Million - $6.04 Million	-69,171 Reduced 52.8%	61,832 $4.7 Million
Q2 2022 Jul 26, 2022	SELL	$80.52 - $93.75 $294,381 - $342,750	-3,656 Reduced 2.72%	131,003 $11.1 Million
Q1 2022 May 10, 2022	SELL	$80.11 - $90.62 $615,725 - $696,505	-7,686 Reduced 5.4%	134,659 $11.8 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $323,582 - $357,807	-4,060 Reduced 2.77%	142,345 $12.5 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $18,155 - $21,121	-222 Reduced 0.15%	146,405 $12 Million
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $17,474 - $19,300	-205 Reduced 0.14%	146,627 $13.4 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $15,280 - $18,020	-183 Reduced 0.12%	146,832 $12.6 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $3.1 Million - $3.75 Million	39,760 Added 37.07%	147,015 $13.9 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $2 Million - $2.22 Million	-24,362 Reduced 18.51%	107,255 $9.33 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $600,581 - $676,053	-7,421 Reduced 5.34%	131,617 $11.5 Million
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $137,806 - $193,069	-1,950 Reduced 1.38%	139,038 $11.5 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $1.58 Million - $1.79 Million	18,783 Added 15.37%	140,988 $13.4 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $380,909 - $419,739	-4,453 Reduced 3.52%	122,205 $10.6 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $2.62 Million - $3.23 Million	34,794 Added 37.88%	126,658 $11.6 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $3 Million - $3.43 Million	-39,833 Reduced 30.25%	91,864 $7.77 Million
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $1.75 Million - $1.95 Million	23,789 Added 22.05%	131,697 $11.3 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $2.02 Million - $2.34 Million	30,227 Added 38.91%	107,908 $9.3 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $6,036 - $6,822	-93 Reduced 0.12%	77,681 $5.87 Million
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $174,356 - $208,439	2,477 Added 3.29%	77,774 $6.29 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $793,315 - $851,555	10,968 Added 17.05%	75,297 $6.32 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $684,608 - $713,511	9,234 Added 16.76%	64,329 $5.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	55,095	55,095 $4.6 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Novartis Ag Transaction History